This study indicated that the GPR, which shows application prospect in HBV mono-infection or HBV/HIV co-infection patients in West Africa, also could be used to identify significant fibrosis, severe fibrosis, and cirrhosis in CHB-NAFLD patients. The gene discussed is ALDH18A1; the disease is metabolic dysfunction-associated steatotic liver disease.